123 related articles for article (PubMed ID: 32096167)
1. MiR-135b-5p inhibits the progression of malignant melanoma cells by targeting RBX1.
Zhang XH; Xin ZM
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1309-1315. PubMed ID: 32096167
[TBL] [Abstract][Full Text] [Related]
2. MiR-135b-5p affected malignant behaviors of ovarian cancer cells by targeting KDM5B.
Ren R; Wu J; Zhou MY
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3548-3554. PubMed ID: 32329828
[TBL] [Abstract][Full Text] [Related]
3. MiR-429-5p attenuates the migration and invasion of malignant melanoma by targeting LIMK1.
Sheng H; Guo YH; Cao DS; Li XJ; Zhao Y; Ding H; Zhang YL; Chen ZH
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2625-2631. PubMed ID: 32196612
[TBL] [Abstract][Full Text] [Related]
4. [miR-122-5p inhibits the proliferation of melanoma cells by targeting NOP14].
Li J; Zhao R; Fang R; Wang J
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1360-1365. PubMed ID: 30514686
[TBL] [Abstract][Full Text] [Related]
5. [miR-590-5p inhibits A375 cell invasion and migration in malignant melanoma by directly inhibiting YAP1 expression].
Wang L; Shi S; Zhou Y; Mu X; Han D; Ge R; Mu K
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Mar; 33(3):326-330. PubMed ID: 28274310
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1.
Xu Y; Zhao S; Cui M; Wang Q
Int J Clin Exp Pathol; 2015; 8(9):10294-304. PubMed ID: 26617737
[TBL] [Abstract][Full Text] [Related]
7. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
[TBL] [Abstract][Full Text] [Related]
8. miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2.
Zhang Z; Che X; Yang N; Bai Z; Wu Y; Zhao L; Pei H
Biomed Pharmacother; 2017 Dec; 96():1341-1348. PubMed ID: 29196101
[TBL] [Abstract][Full Text] [Related]
9. MiR-135b is a novel oncogenic factor in cutaneous melanoma by targeting LATS2.
Hu Y; Wang Q; Zhu XH
Melanoma Res; 2019 Apr; 29(2):119-125. PubMed ID: 30480622
[TBL] [Abstract][Full Text] [Related]
10. MiR-338-5p promotes the growth and metastasis of malignant melanoma cells via targeting CD82.
Long J; Luo J; Yin X
Biomed Pharmacother; 2018 Jun; 102():1195-1202. PubMed ID: 29710538
[TBL] [Abstract][Full Text] [Related]
11. Identification of FLOT2 as a novel target for microRNA-34a in melanoma.
Liu R; Xie H; Luo C; Chen Z; Zhou X; Xia K; Chen X; Zhou M; Cao P; Cao K; Zhou J
J Cancer Res Clin Oncol; 2015 Jun; 141(6):993-1006. PubMed ID: 25403318
[TBL] [Abstract][Full Text] [Related]
12. Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC.
Zhao CC; Jiao Y; Zhang YY; Ning J; Zhang YR; Xu J; Wei W; Kang-Sheng G
Cell Death Dis; 2019 Mar; 10(4):252. PubMed ID: 30874550
[TBL] [Abstract][Full Text] [Related]
13. LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis.
Chen N; Yin D; Lun B; Guo X
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30429236
[TBL] [Abstract][Full Text] [Related]
14. MiR-212-5p inhibits the malignant behavior of clear cell renal cell carcinoma cells by targeting TBX15.
Deng JH; Zheng GY; Li HZ; Ji ZG
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10699-10707. PubMed ID: 31858538
[TBL] [Abstract][Full Text] [Related]
15. miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3/AKT3 in uveal melanoma.
Li J; Liu X; Li C; Wang W
J Cell Biochem; 2019 Aug; 120(8):12412-12421. PubMed ID: 30825222
[TBL] [Abstract][Full Text] [Related]
16. miR-135b promotes proliferation and metastasis by targeting APC in triple-negative breast cancer.
Lv ZD; Xin HN; Yang ZC; Wang WJ; Dong JJ; Jin LY; Li FN
J Cell Physiol; 2019 Jul; 234(7):10819-10826. PubMed ID: 30624764
[TBL] [Abstract][Full Text] [Related]
17. miR-182 and miR-135b Mediate the Tumorigenesis and Invasiveness of Colorectal Cancer Cells via Targeting ST6GALNAC2 and PI3K/AKT Pathway.
Jia L; Luo S; Ren X; Li Y; Hu J; Liu B; Zhao L; Shan Y; Zhou H
Dig Dis Sci; 2017 Dec; 62(12):3447-3459. PubMed ID: 29030743
[TBL] [Abstract][Full Text] [Related]
18. miR-194 targets RBX1 gene to modulate proliferation and migration of gastric cancer cells.
Chen X; Wang Y; Zang W; Du Y; Li M; Zhao G
Tumour Biol; 2015 Apr; 36(4):2393-401. PubMed ID: 25412959
[TBL] [Abstract][Full Text] [Related]
19. Targeting GOLM1 by microRNA-200a in melanoma suppresses cell proliferation, invasion and migration via regulating PI3K/Akt signaling pathway and epithelial-mesenchymal transition.
Chen WY; Xu YY; Zhang XY
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6997-7007. PubMed ID: 31486500
[TBL] [Abstract][Full Text] [Related]
20. MiR-155 inhibits proliferation, invasion and migration of melanoma via targeting CBL.
Li H; Song JB; Chen HX; Wang QQ; Meng LX; Li Y
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9525-9534. PubMed ID: 31773704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
